Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bio-Technology General in-licenses PEG-uricase for development

Aug. 26, 1998

Antidiabetes drug from Amylin enters phase I clinical study

Aug. 26, 1998

Lilly describes promising beta3-adrenoceptor agonist at ACS meeting

Aug. 25, 1998

Viagra and nitrates: a lethal combination

Aug. 25, 1998

EU approval granted for Novo's orally active antidiabetic agent NovoNorm

Aug. 24, 1998

Amgen discontinues clinical testing of PEG-rHuMGDF for one of two indications

Aug. 21, 1998

New tocolytic agents in the pipeline at Kissei

Aug. 21, 1998

SmithKline Beecham licenses rights to Immunex's G-CSF receptor for R&D purposes

Aug. 21, 1998

Viagra marketing application filed in Japan

Aug. 20, 1998

Merck investigators discover new glucagon antagonists

Aug. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...